Lv61
2710 积分 2022-03-15 加入
Plasma proteomics framework predicts metabolic dysfunction-associated steatotic liver disease up to 16 years before onset
2个月前
已完结
Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis
7个月前
已完结
The origin of hepatocellular carcinoma depends on metabolic zonation
7个月前
已完结
A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration
8个月前
已关闭
A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration
8个月前
已完结
STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway
11个月前
已完结
Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses
1年前
已完结
Membrane phospholipid remodeling modulates nonalcoholic steatohepatitis progression by regulating mitochondrial homeostasis
1年前
已完结
Metabolic Dysfunction-Associated Steatotic Liver Disease
1年前
已完结
Use of liver stiffness measurement for hepatocellular carcinoma risk stratification in metabolic dysfunction associated steatotic liver disease
1年前
已关闭
皖公网安备34019202002308
